In response to this consumer enthusiasm, health systems are pouring resources into wearable device programs that promise continuous insight into patients’ health. These devices can monitor everything ...

DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the company ...

Connacht can still book their place in the knockout stages of the European Challenge Cup with a win at home to Montauban on ...

In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...

In addition to Canaccord Genuity, Dexcom also received a Buy from TD Cowen’s Josh Jennings in a report issued yesterday. However, on the same day, Barclays reiterated a Sell rating on Dexcom (NASDAQ: ...

Connacht are on the hunt to bag maximum points against Montauban in their final European Challenge Cup pool fixture to ensure ...

Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something ...

Jake Leach, Dexcom CEO, joins 'Closing Bell Overtime' to talk its 2026 outlook, the impact of GLP-1s, new devices and more.

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

Finlay Bealham, Hugh Gavin and Shayne Bolton will be unavailable for Connacht for the coming weeks as Connacht issue an ...

Fintel reports that on January 12, 2026, Barclays downgraded their outlook for DexCom (NasdaqGS:DXCM) from Equal-Weight to ...

Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus ...